Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Perception of Information and Quality of Life in Neuroendocrine Tumor on Lanreotide Autogel

NCT03562091 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03562091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Perception of Information and Quality of Life in Neuroendocrine Tumor on Lanreotide Autogel
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
July 20, 2018
Completion date
May 15, 2020
Enrollment
115 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroendocrine tumors